These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 10579819

  • 1. Metabolism-based brain-targeting system for a thyrotropin-releasing hormone analogue.
    Prokai L, Prokai-Tatrai K, Ouyang X, Kim HS, Wu WM, Zharikova A, Bodor N.
    J Med Chem; 1999 Nov 04; 42(22):4563-71. PubMed ID: 10579819
    [Abstract] [Full Text] [Related]

  • 2. Design, synthesis, and biological evaluation of novel, centrally-acting thyrotropin-releasing hormone analogues.
    Prokai-Tatrai K, Perjési P, Zharikova AD, Li X, Prokai L.
    Bioorg Med Chem Lett; 2002 Aug 19; 12(16):2171-4. PubMed ID: 12127530
    [Abstract] [Full Text] [Related]

  • 3. Centrally acting and metabolically stable thyrotropin-releasing hormone analogues by replacement of histidine with substituted pyridinium.
    Prokai L, Prokai-Tatrai K, Zharikova AD, Nguyen V, Perjesi P, Stevens SM.
    J Med Chem; 2004 Nov 18; 47(24):6025-33. PubMed ID: 15537357
    [Abstract] [Full Text] [Related]

  • 4. A pyridinium-substituted analog of the TRH-like tripeptide pGlu-Glu-Pro-NH2 and its prodrugs as central nervous system agents.
    Prokai-Tatrai K, Teixido M, Nguyen V, Zharikova AD, Prokai L.
    Med Chem; 2005 Mar 18; 1(2):141-52. PubMed ID: 16787309
    [Abstract] [Full Text] [Related]

  • 5. Prodrugs to enhance central nervous system effects of the TRH-like peptide pGlu-Glu-Pro-NH2.
    Prokai-Tatrai K, Nguyen V, Zharikova AD, Braddy AC, Stevens SM, Prokai L.
    Bioorg Med Chem Lett; 2003 Mar 24; 13(6):1011-4. PubMed ID: 12643900
    [Abstract] [Full Text] [Related]

  • 6. Neuropharmacodynamic evaluation of the centrally active thyrotropin-releasing hormone analogue [Leu2]TRH and its chemical brain-targeting system.
    Prokai L, Zharikova AD.
    Brain Res; 2002 Oct 18; 952(2):268-74. PubMed ID: 12376188
    [Abstract] [Full Text] [Related]

  • 7. Brain-targeted chemical delivery of [Leu2, Pip3]-TRH: synthesis and biological evaluation.
    Yoon SH, Wu J, Wu WM, Prokai L, Bodor N.
    Bioorg Med Chem; 2000 May 18; 8(5):1059-63. PubMed ID: 10882017
    [Abstract] [Full Text] [Related]

  • 8. Role of TRH receptors as possible mediators of analeptic actions of TRH-like peptides.
    Hinkle PM, Pekary AE, Senanayaki S, Sattin A.
    Brain Res; 2002 May 10; 935(1-2):59-64. PubMed ID: 12062473
    [Abstract] [Full Text] [Related]

  • 9. TRH analogue with C-terminal thioamide group. Synthesis, receptor binding, TSH-releasing activity and alpha-MSH-releasing activity.
    Kruszyński M, Kupryszewski G, Ragnarsson U, Alexandrova M, Strbak V, Tonon MC, Vaudry H.
    Experientia; 1985 Dec 15; 41(12):1576-7. PubMed ID: 3000815
    [Abstract] [Full Text] [Related]

  • 10. Evidence for interplay between thyrotropin-releasing hormone (TRH) and its structural analogue pGlu-Glu-Pro-NH2 ([Glu2]TRH) in the brain: an in vivo microdialysis study.
    Nguyen V, Zharikova AD, Prokai L.
    Neurosci Lett; 2007 Mar 19; 415(1):64-7. PubMed ID: 17234338
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Pro-thyrotropin-releasing hormone processing by recombinant PC1.
    Nillni EA, Friedman TC, Todd RB, Birch NP, Loh YP, Jackson IM.
    J Neurochem; 1995 Dec 19; 65(6):2462-72. PubMed ID: 7595540
    [Abstract] [Full Text] [Related]

  • 13. Prodrugs of thyrotropin-releasing hormone and related peptides as central nervous system agents.
    Prokai-Tatrai K, Prokai L.
    Molecules; 2009 Feb 06; 14(2):633-54. PubMed ID: 19214153
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Two novel thioamide analogues of TRH with selective activity on CNS.
    Alexandrová M, Strbák V, Kruszynski M, Zboinska J, Kupryszewski G.
    Gen Physiol Biophys; 1991 Jun 06; 10(3):287-97. PubMed ID: 1655558
    [Abstract] [Full Text] [Related]

  • 17. Release of thyrotropin and prolactin by a thyrotropin-releasing hormone (TRH) precursor, TRH-Gly: conversion to TRH is sufficient for in vivo effects.
    Pekary AE, Stephens R, Simard M, Pang XP, Smith V, DiStefano JJ, Hershman JM.
    Neuroendocrinology; 1990 Dec 06; 52(6):618-25. PubMed ID: 2126612
    [Abstract] [Full Text] [Related]

  • 18. Distribution of thyrotropin-releasing hormone (TRH) and precursor peptide (TRH-Gly) in adult rat tissues.
    Fuse Y, Polk DH, Lam RW, Fisher DA.
    Endocrinology; 1990 Nov 06; 127(5):2501-5. PubMed ID: 2121465
    [Abstract] [Full Text] [Related]

  • 19. [β-Glu2]TRH Is a Functional Antagonist of Thyrotropin-Releasing Hormone (TRH) in the Rodent Brain.
    Prokai-Tatrai K, Nguyen V, Prokai L.
    Int J Mol Sci; 2021 Jun 09; 22(12):. PubMed ID: 34207724
    [Abstract] [Full Text] [Related]

  • 20. Evidence for thyrotropin-releasing hormone (TRH) biosynthesis in rat prostate.
    Pekary AE, Reeve JR, Smith VP.
    Life Sci; 1986 Dec 29; 39(26):2565-70. PubMed ID: 3099113
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.